Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetershill Regulatory News (PHLL)

  • This share is currently suspended. It was suspended at a price of 310.50
  • There is currently no data for PHLL

Form 8.3 PETERSHILL PARTNERS PLC

27 Nov 2025 13:01

RNS Number : 3247J
Barclays PLC
27 November 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

PETERSHILL PARTNERS PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

26 Nov 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

USD 0.01 ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

11,444,340

1.06%

897,195

0.08%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

874,564

0.08%

11,430,299

1.06%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

12,318,904

1.14%

12,327,494

1.14%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

USD 0.01 ordinary

Purchase

248,661

3.1250 GBP

USD 0.01 ordinary

Purchase

74,446

3.1400 GBP

USD 0.01 ordinary

Purchase

64,015

3.1252 GBP

USD 0.01 ordinary

Purchase

51,697

3.1377 GBP

USD 0.01 ordinary

Purchase

29,905

3.1251 GBP

USD 0.01 ordinary

Purchase

25,000

3.1300 GBP

USD 0.01 ordinary

Purchase

5,998

3.1350 GBP

USD 0.01 ordinary

Purchase

2,900

3.1419 GBP

USD 0.01 ordinary

Purchase

2,400

3.1406 GBP

USD 0.01 ordinary

Purchase

7

3.1500 GBP

USD 0.01 ordinary

Sale

135,997

3.1252 GBP

USD 0.01 ordinary

Sale

72,128

3.1250 GBP

USD 0.01 ordinary

Sale

66,985

3.1372 GBP

USD 0.01 ordinary

Sale

31,993

3.1268 GBP

USD 0.01 ordinary

Sale

31,710

3.1300 GBP

USD 0.01 ordinary

Sale

24,278

3.1354 GBP

USD 0.01 ordinary

Sale

12,495

3.1350 GBP

USD 0.01 ordinary

Sale

5,384

3.1327 GBP

USD 0.01 ordinary

Sale

5,023

3.1384 GBP

USD 0.01 ordinary

Sale

1,257

3.1400 GBP

USD 0.01 ordinary

Sale

795

3.1450 GBP

USD 0.01 ordinary

Sale

7

3.1500 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

USD 0.01 ordinary

SWAP

Decreasing Short

2,301

3.1250 GBP

USD 0.01 ordinary

SWAP

Decreasing Short

1

3.1350 GBP

USD 0.01 ordinary

SWAP

Increasing Short

10,279

3.1250 GBP

USD 0.01 ordinary

SWAP

Increasing Short

3,905

3.1251 GBP

USD 0.01 ordinary

SWAP

Increasing Short

46

3.1350 GBP

USD 0.01 ordinary

SWAP

Increasing Short

74,437

3.1400 GBP

USD 0.01 ordinary

CFD

Decreasing Short

31,710

3.1300 GBP

USD 0.01 ordinary

CFD

Decreasing Short

6,461

3.1350 GBP

USD 0.01 ordinary

CFD

Decreasing Short

66,985

3.1372 GBP

USD 0.01 ordinary

CFD

Increasing Short

60,934

3.1250 GBP

USD 0.01 ordinary

CFD

Increasing Short

25,000

3.1300 GBP

USD 0.01 ordinary

CFD

Increasing Short

51,697

3.1377 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

27 Nov 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETFLFEFLSLDFIE
Date   Source Headline
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 20227:00 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 20222:30 pmRNSResult of AGM
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 20227:00 amRNSQ1 Trading Update
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 20227:00 amRNSTransaction in Own Shares
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSShare Buyback Programme of up to USD$50 Million
3rd May 202211:17 amRNSDirector/PDMR Shareholding
29th Apr 20227:00 amRNSNotice of AGM and Proposed Final Dividend
27th Apr 20227:00 amRNS2021 Annual Report and Accounts
20th Apr 20227:00 amRNSFull-Year Financial Results
18th Jan 20227:00 amRNSAcquisition Update
16th Dec 202112:30 pmRNSDirector/PDMR Shareholding
26th Nov 20219:37 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSQ3 Trading Update
3rd Nov 20212:51 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSNotice of Q3 2021 Trading Statement Release
1st Nov 20217:00 amRNSTotal Voting Rights
28th Oct 20217:00 amRNSExercise of Over-allotment Option
28th Oct 20217:00 amRNSEnd of Stabilisation Notice
26th Oct 20214:36 pmRNSStabilisation Notice
19th Oct 20214:36 pmRNSStabilisation Notice
12th Oct 20214:36 pmRNSStabilisation Notice
11th Oct 20214:21 pmRNSHolding(s) in Company
8th Oct 202111:01 amRNSHolding(s) in Company
7th Oct 202112:45 pmRNSHolding(s) in Company
7th Oct 202112:30 pmRNSHolding(s) in Company
5th Oct 20214:36 pmRNSStabilisation Notice
1st Oct 20218:30 amRNSDirector/PDMR Shareholding
1st Oct 20218:00 amRNSAdmission to Trading on the London Stock Exchange
28th Sep 202112:59 pmRNSAnnouncement of Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.